[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100269053":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":11,"centralContacts":22,"locations":27,"responsibleParty":64,"collaborators":11,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":11,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":87,"overallStatus":30,"whyStopped":11,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Metcela Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Autologous cardiac stem cells (JRM-001)","EXPERIMENTAL",null,[13],"Genetic: Autologous cardiac stem cells (JRM-001)",{"label":15,"type":16,"description":11,"interventionNames":11},"Usual care","NO_INTERVENTION",[18],{"type":19,"name":9,"description":20,"armGroupLabels":21,"otherNames":11},"GENETIC","3x 10\\^5 cells\u002Fkg, single treatment",[9],[23],{"name":24,"role":25,"phone":11,"phoneExt":11,"email":26},"Metcela Inc. (former Japan Regenerative Medicine Co., Ltd.)","CONTACT","info@j-rm.com",[28,40,48,56],{"facility":29,"status":30,"city":31,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":11},"Kanagawa Children's Medical Center","RECRUITING","Kanagawa","Japan","JP",{"type":35,"coordinates":36},"Point",[37,38],139.91667,37.58333,{"lat":38,"lon":37},{"facility":41,"status":30,"city":42,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":43,"geoPoint":47,"contacts":11},"Okayama University Hospital","Okayama",{"type":35,"coordinates":44},[45,46],133.93333,34.65,{"lat":46,"lon":45},{"facility":49,"status":30,"city":50,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":51,"geoPoint":55,"contacts":11},"Saitama Prefectural Children's Medical Center","Saitama",{"type":35,"coordinates":52},[53,54],139.65657,35.90807,{"lat":54,"lon":53},{"facility":57,"status":30,"city":58,"state":11,"zip":11,"country":32,"countryCode":33,"cosmosGeoPoint":59,"geoPoint":63,"contacts":11},"Shizuoka Children's Hospital","Shizuoka",{"type":35,"coordinates":60},[61,62],138.38333,34.98333,{"lat":62,"lon":61},{"type":65,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100269053","phase-3-cardiac-stemprogenitor-cell-infusion-in-univentricular-physiology-apollon-trial-100269053",false,"NCT02781922","Cardiac Stem\u002FProgenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)","Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study","APOLLON","Inclusion Criteria:\n\n* Functional single ventricle patient with heart failure who is scheduled for stage 2 (Glenn) or stage 3 (Fontan) surgery\n* EF(%) by echocardiography ≤ 55%\n* Able to obtain written informed consent of participation in the study by a parent of the patient\n\nExclusion Criteria:\n\n* Known medical history of cardiogenic shock\n* Lethal, uncontrollable arrhythmia\n* Complication of coronary artery disease\n* Eisenmenger syndrome\n* Complication of brain dysfunction due to circulatory failure\n* Malignant neoplasm\n* Complication of severe neurologic disorder\n* Severe pulmonary embolism or pulmonary hypertension\n* Severe renal failure\n* Multiple organ failure\n* Active infection (including endocarditis)\n* Sepsis\n* Active hemorrhagic disease (e.g. gastrointestinal bleeding, injury)\n* Known history of hypersensitivity to anti-infective drugs\n* Inability to complete the protocol treatment and baseline to follow-up examinations","ALL","0 Years","6 Years",{"count":78,"type":79},40,"ESTIMATED","INTERVENTIONAL",[82],"PHASE3","The purpose of this study is to evaluate the efficacy and safety of intracoronary injection of JRM-001 after reconstructive surgery in pediatric patients with functional single ventricle",[85,86],"Hypoplastic Left Heart Syndrome","Single Ventricle",[88,89,90,91],"cardiac stem\u002Fprogenitor cells","autologous cell therapy","functional single ventricle","congenital heart disease","2025-09-24",{"date":94,"type":95},"2025-09-30","ACTUAL",{"date":97,"type":11},"2016-06",{"date":99,"type":79},"2028-12",{"name":5,"class":6},4]